A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Erythrodermic psoriasis; Plaque psoriasis; Psoriatic arthritis; Pustular psoriasis
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 09 Apr 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 20 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Sep 2012 New trial record